Fate Therapeutics FATE
NASDAQ FATE
$2.11 +0.02 (+0.96%)
At close: Oct 23, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Sale and Maturity of Investments (2016 - 2026)

Updated

Analysis

Fate Therapeutics (FATE) Sale and Maturity of Investments (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Fate Therapeutics 246.22 Mn 92.42 Mn - 72.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 72.98 Mn
Mar 31, 2026 52.56 Mn
Dec 31, 2025 66.32 Mn
Sep 30, 2025 81.45 Mn
Jun 30, 2025 71.64 Mn
Mar 31, 2025 92.49 Mn
Dec 31, 2024 60.92 Mn
Sep 30, 2024 90.70 Mn
Jun 30, 2024 75.34 Mn
Mar 31, 2024 103.74 Mn
Dec 31, 2023 95.50 Mn
Sep 30, 2023 127.50 Mn
Jun 30, 2023 127.63 Mn
Mar 31, 2023 127.00 Mn
Dec 31, 2022 166.89 Mn
Sep 30, 2022 190.63 Mn
Jun 30, 2022 114.37 Mn
Mar 31, 2022 135.22 Mn
Dec 31, 2021 263.09 Mn
Sep 30, 2021 258.16 Mn
API Access

Fate Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=FATE&period=max&api_key=YOUR_API_KEY